Autonomic Pharmacology - USMLE Step 1

1. Based on the mechanism of action of oxybutynin, which of the following side effects is she most likely experiencing?
   Answer: Dry mouth Oxybutynin is an antimuscarinic agent that blocks M3 receptors on the detrusor muscle, causing it to relax and increasing bladder capacity. However, it also blocks muscarinic receptors elsewhere in the body, leading to classic anticholinergic side effects. These include dry mouth (xerostomia) due to blockade of M3 receptors on salivary glands, constipation, blurred vision, and confusion, especially in the elderly.
2. This patient's symptoms are most likely due to which of the following effects of the medication?
   Answer: First-dose orthostatic hypotension Prazosin is an alpha-1 adrenergic antagonist. It blocks alpha-1 receptors on both arterial and venous smooth muscle, causing vasodilation and a decrease in blood pressure. A well-known adverse effect, particularly with the first dose or after a dose increase, is orthostatic hypotension. This occurs because the blockade of venous alpha-1 receptors prevents the normal vasoconstrictor response needed to maintain blood pressure upon standing.
3. The use of propranolol is relatively contraindicated in this patient due to its potential to cause which of the following?
   Answer: Bronchoconstriction Propranolol is a non-selective beta-blocker, meaning it antagonizes both beta-1 and beta-2 adrenergic receptors. While the beta-1 blockade is beneficial for the heart post-MI, the blockade of beta-2 receptors in the lungs is problematic. Beta-2 receptors mediate bronchodilation. Blocking them can lead to bronchoconstriction, which can precipitate a severe asthma attack in susceptible individuals. Cardioselective beta-1 blockers (e.g., metoprolol, atenolol) are preferred in such patients.
4. Varenicline accomplishes these dual effects by acting as which of the following at central nicotinic acetylcholine receptors?
   Answer: Partial agonist Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor subtype. As a partial agonist, it provides a moderate, sustained level of dopamine release in the mesolimbic pathway, which helps to reduce cravings and withdrawal symptoms (agonist activity). At the same time, it occupies the receptor and prevents nicotine from binding, thereby blocking the rewarding effects of smoking (antagonist activity).
5. Which of the following best describes the mechanism of action of the administered drug?
   Answer: Direct stimulation of muscarinic receptors on the detrusor muscle Bethanechol is a direct-acting cholinomimetic that selectively stimulates muscarinic receptors, particularly M3 receptors on the detrusor muscle of the bladder and on smooth muscle of the GI tract. This stimulation leads to detrusor muscle contraction and relaxation of the trigone and sphincter, promoting urination. It is used to treat non-obstructive urinary retention.
6. The medication in the patch, most likely scopolamine, exerts its antiemetic effect by blocking which class of receptors in the central nervous system?
   Answer: Muscarinic cholinergic receptors Scopolamine is a centrally acting antimuscarinic agent. It is particularly effective for motion sickness because it blocks muscarinic receptors in the vestibular system and the brainstem vomiting center. The side effects of drowsiness and dry mouth are due to its central and peripheral anticholinergic properties, respectively.
7. In addition to atropine, which of the following medications should be administered to regenerate the affected enzyme and treat the nicotinic effects?
   Answer: Pralidoxime Organophosphates are irreversible acetylcholinesterase inhibitors. Atropine is a muscarinic antagonist that competitively blocks the effects of excess acetylcholine at muscarinic receptors, treating symptoms like bradycardia, salivation, and bronchospasm. However, it has no effect on nicotinic receptors (responsible for muscle fasciculations and weakness). Pralidoxime is a cholinesterase reactivator that removes the organophosphate from the enzyme, restoring its function. It must be given early, before the bond 'ages'.
8. The primary desired hemodynamic effect of dobutamine in this patient is an increase in which of the following?
   Answer: Myocardial contractility Dobutamine is a synthetic catecholamine that is primarily a beta-1 adrenergic agonist. Stimulation of beta-1 receptors in the heart leads to a significant increase in myocardial contractility (positive inotropy) and, to a lesser extent, heart rate. This improves cardiac output and organ perfusion in cardiogenic shock. Dobutamine also has weak beta-2 agonist activity, which can cause mild vasodilation and a decrease in systemic vascular resistance (afterload).
9. What is the primary mechanism by which clonidine exerts its antihypertensive effect?
   Answer: Stimulation of central presynaptic alpha-2 receptors Clonidine is a centrally acting alpha-2 adrenergic agonist. It stimulates alpha-2 receptors in the brainstem (specifically the nucleus tractus solitarii), which inhibits presynaptic release of norepinephrine. This leads to a decrease in central sympathetic outflow, reducing heart rate, cardiac output, and peripheral vascular resistance, thereby lowering blood pressure.
10. Which of the following is the most likely mechanism of the drug used to treat her muscle weakness?
    Answer: Reversibly inhibits acetylcholinesterase Myasthenia gravis is treated with acetylcholinesterase (AChE) inhibitors, such as pyridostigmine or neostigmine. These drugs reversibly inhibit AChE, the enzyme that degrades acetylcholine in the synaptic cleft. This action increases the concentration and duration of action of acetylcholine at the neuromuscular junction, improving muscle strength. The side effects (cramps, diarrhea) are due to increased muscarinic stimulation in the GI tract.
11. The unique therapeutic benefit of carvedilol in this condition is derived from its antagonist activity at which combination of receptors?
    Answer: Alpha-1, Beta-1, and Beta-2 Carvedilol (and labetalol) are non-selective beta-blockers that also have alpha-1 blocking properties. In heart failure, the beta-1 blockade reduces the harmful effects of chronic sympathetic stimulation on the heart (e.g., remodeling, apoptosis). The alpha-1 blockade causes peripheral vasodilation, which reduces both preload and afterload, further decreasing the workload on the failing heart.
12. What is the primary mechanism by which ipratropium provides therapeutic benefit in this patient?
    Answer: Antagonism of muscarinic receptors, leading to bronchodilation Ipratropium is a short-acting muscarinic antagonist (SAMA). It competitively blocks muscarinic receptors (primarily M3) on airway smooth muscle, preventing acetylcholine-induced bronchoconstriction. This results in bronchodilation. It is a quaternary amine, so it does not readily cross the blood-brain barrier and has minimal systemic side effects.
13. How does pilocarpine help to lower intraocular pressure in this condition?
    Answer: Contracting the ciliary muscle, which opens the trabecular meshwork Pilocarpine is a direct-acting muscarinic agonist. In the eye, it causes contraction of the ciliary muscle (a parasympathetic action). This contraction pulls on the trabecular meshwork, increasing the outflow of aqueous humor and thereby lowering intraocular pressure. It also causes miosis (pupillary constriction), which can further help open the angle in angle-closure glaucoma.
14. The therapeutic effect of phenylephrine in this patient is mediated primarily by the stimulation of which of the following receptors?
    Answer: Alpha-1 adrenergic Phenylephrine is a selective alpha-1 adrenergic agonist. Activation of alpha-1 receptors on vascular smooth muscle causes potent vasoconstriction, which increases systemic vascular resistance (SVR) and, consequently, blood pressure. It has minimal effect on beta receptors, so it does not directly increase heart rate or contractility and may cause a reflex bradycardia.
15. Which of the following best describes the mechanism by which pyridostigmine improves muscle strength in this patient?
    Answer: It increases the duration of acetylcholine in the synaptic cleft. Pyridostigmine is a long-acting, reversible acetylcholinesterase (AChE) inhibitor. By inhibiting the AChE enzyme, it prevents the breakdown of acetylcholine in the neuromuscular junction. This increases the concentration and prolongs the half-life of acetylcholine in the synaptic cleft, allowing it to better compete for the reduced number of functional nicotinic receptors characteristic of myasthenia gravis, thereby improving neuromuscular transmission and muscle strength.
16. Tamsulosin has a lower incidence of orthostatic hypotension compared to prazosin because of its relative selectivity for which receptor subtype, which is concentrated in the prostate and bladder neck?
    Answer: Alpha-1A Alpha-1 receptors have subtypes. Alpha-1A receptors are predominantly found in the smooth muscle of the prostate and bladder neck, and their blockade by tamsulosin relaxes these tissues, improving urinary flow in BPH. Alpha-1B receptors are primarily found in vascular smooth muscle. Prazosin is non-selective for these subtypes and blocks both, leading to significant vasodilation and a risk of orthostatic hypotension. Tamsulosin's selectivity for Alpha-1A makes it uroselective with fewer vascular side effects.
17. This patient's toxidrome is caused by the antagonism of which of the following receptors?
    Answer: Muscarinic cholinergic receptors The patient is presenting with classic anticholinergic (antimuscarinic) toxicity, often remembered by the mnemonic 'hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter.' The toxins in Atropa belladonna, such as atropine and scopolamine, are potent competitive antagonists of muscarinic cholinergic receptors, leading to inhibition of parasympathetic functions.
18. Unlike oxybutynin, mirabegron improves symptoms of overactive bladder through which of the following mechanisms?
    Answer: Stimulation of beta-3 adrenergic receptors on the detrusor muscle Mirabegron is a beta-3 adrenergic agonist. Stimulation of beta-3 receptors on the detrusor muscle leads to smooth muscle relaxation, which increases the bladder's capacity to store urine and reduces symptoms of urgency and frequency. This mechanism is distinct from antimuscarinic drugs like oxybutynin, which block M3 receptors to prevent involuntary bladder contractions. Because mirabegron does not affect muscarinic receptors, it avoids the typical anticholinergic side effects.
19. These adverse effects are best explained by albuterol's stimulation of which of the following receptors?
    Answer: Beta-2 receptors in skeletal muscle and cardiac tissue Albuterol is a short-acting beta-2 selective adrenergic agonist used for bronchodilation. However, at higher doses or with frequent use, its selectivity decreases. The tremor (shaky hands) results from stimulation of beta-2 receptors in skeletal muscle. The tachycardia (heart racing) occurs due to stimulation of both beta-2 receptors present in cardiac tissue and some cross-reactivity with cardiac beta-1 receptors at higher doses.
20. Which of the following effects of epinephrine is most critical for reversing this patient's life-threatening hypotension?
    Answer: Alpha-1 receptor-mediated vasoconstriction In anaphylactic shock, massive histamine release causes widespread vasodilation and capillary leak, leading to profound hypotension. Epinephrine is the treatment of choice because it addresses all aspects of anaphylaxis. However, the most critical life-saving effect for reversing shock is its potent alpha-1 agonist activity, which causes vasoconstriction, increases systemic vascular resistance, and raises blood pressure. The beta-2 effects (bronchodilation) and beta-1 effects (increased cardiac output) are also crucial but secondary to vasoconstriction for treating the shock itself.

Start this quiz